The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causes.
Authors:David G Taylor|||Francois Giuliano|||Geoff Hackett|||Evelyn Hermes-DeSantis|||Michael G Kirby|||Robert A Kloner|||Terry Maguire|||Vera Stecher|||Paul Goggin
Journal: Research in social & administrative pharmacy : RSAP
Publication Type: Journal Article
Date: 2019
DOI: 10.1016/j.sapharm.2018.07.014
ID: 30057329
Affiliations:
Affiliations
The UCL School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK. Electronic address: David.G.Taylor@ucl.ac.uk.|||Neurourology R. Poincaré Hal Garches, Versailles Saint-Quentin University, 104 Boulevard Raymond Poincaré, Garches, 92380, France. Electronic address: francois.giuliano@uvsq.fr.|||Good Hope Hospital, Rectory Road, Sutton Coldfield, Birmingham, B75 7RR, UK. Electronic address: hackettgeoff@gmail.com.|||Ernest Mario School of Pharmacy, Rutgers University, 160 Frelinghuysen Road, New Brunswick, NJ, 08854, USA. Electronic address: ehermesd@pharmacy.rutgers.edu.|||The Prostate Centre, 32 Wimpole St, Marylebone, London W1G 8GT, UK; University of Hertfordshire, Centre for Research in Primary and Community Care, College Lane, Hatfield, Hertfordshire, AL10 9AB, UK. Electronic address: kirbym@globalnet.co.uk.|||Huntington Medical Research Institutes, 686 S Fair Oaks Ave, Pasadena, CA 91105, USA; Division of Cardiovascular Medicine, Dept. of Medicine, Keck School of Medicine at University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. Electronic address: Robert.Kloner@hmri.org.|||Queens University Belfast, University Road, Belfast, BT7 1NN, UK, Ireland. Electronic address: t.maguire@qub.ac.uk.|||Pfizer Inc, 235 E 42nd St, New York, NY, 10017, USA. Electronic address: Vera.Stecher@Pfizer.com.|||Pfizer Ltd, Discovery Park, Ramsgate Rd, Sandwich, CT13 9ND, UK. Electronic address: Paul.Goggin@pfizer.com.
Abstract
Erectile dysfunction (ED), which worldwide is likely to affect in excess of 300 million men by 2025, is often either untreated or insufficiently treated. It can be a prelude to other serious illnesses and may be a cause or consequence of depression in affected individuals. Among men younger than 60 years of age, ED can be a robust early-stage indicator of vascular disease and type 2 diabetes. Untreated or inadequately treated ED can also be a sign of poor communication between health professionals and service users of all ages. Improved treatment of ED could cost-effectively prevent premature deaths and avoidable morbidity. The extension of community pharmacy‒based health care would enable more men living with ED to safely access effective medications, along with appropriate diagnostic services and support for beneficial lifestyle changes such as smoking cessation in conveniently accessible settings. The task of introducing improved methods of affordably addressing problems linked to ED exemplifies the strategic challenges now facing health care systems globally. Promoting professionally supported self-care in pharmacies has the potential to meet the needs of aging populations in progressively more effective ways.
